ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2419

Single-Cell Analysis of CD163 mRNA and Protein Expression By Primeflow™ in Polarized Monocyte and Macrophage Populations

Rachel Tan1, Sherry Thornton2, Alyssa Sproles2, Thuy Do3, Jonathan Schick4, Monica DeLay4 and Grant Schulert5, 1University of Cincinnati, Cincinnati, OH, 2Division of Rheumatology, Cincinnati Children's Hospital, Cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Cincinnati Children's Hospital, Cincinnati, OH, 5Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: flow cytometry and monocytes, Macrophage, Systemic JIA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Pediatric Rheumatology – Pathogenesis and Genetics - Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  CD163 is involved in the regulation and resolution of innate inflammation and the removal of free hemoglobin from the blood via internalization of the hemoglobin-haptoglobin complex. It is also a cell surface marker of alternatively activated macrophages overexpressed in inflammatory disorders such as systemic juvenile idiopathic arthritis. To better understand the activation of myeloid cells in rheumatic disorders, a flow cytometry panel has been developed to define polarized monocyte and macrophage phenotypes. Along with detecting surface protein markers, the novel technique called PrimeFlow™ allows specific mRNA sequences to be detected at single cell resolution. This panel was utilized to define the expression of CD163 in polarized monocyte and macrophage populations.

Methods:  A human monocytic cell line, THP-1, was cultured and stimulated in vitro with LPS and IFN-gamma, IL-4, LPS and IgG, TGFβ, or IL-10 toward M1, M2a, M2b, and M2c phenotypes, respectively. The cells were stained using the fluorochrome conjugated antibodies CD14-Pacific Blue, CD16-BV711, CD80-BV786, CD64-AF700, CD209-FITC and CD163-PE. Each condition also was stained for CD163 mRNA using the PrimeFlow™ kit’s branching technology. Cells were acquired using an analytical cytometer, and data were analyzed by FACSDiva software.

Results:  PrimeFlow™ staining of CD163 mRNA could reliably detect increased CD163 expression in THP-1 monocytic cells, primary CD14+ blood monocytes, and monocyte-derived macrophages. The PrimeFlow™ CD163 mRNA probe was also used simultaneously to detect protein surface markers, and this flow cytometry panel provided the same degree of positively stained cells as the results of staining for individual cell surface markers without mRNA labeling. This combined panel demonstrated that some alternatively activated populations, such as M2a (IL-4 conditions), show an increase in CD163 surface protein expression with no change in CD163 mRNA levels. In marked contrast and in agreement with qPCR data, increase in both CD163 mRNA and protein levels is limited to the IL-10 stimulated M2c conditions. The PrimeFlow™ technique was determined to be highly sensitive for increased mRNA expression, with a strong signal over a broad range of IL-10 concentrations in contrast to qPCR data and surface protein detection. The kinetics of CD163 induction with IL-10 stimulation were shown to be similar for both mRNA and protein. There is minimal increase in both mRNA and protein expression after 5 hours of stimulation, but significant increase after 24 hours.

Conclusion:  PrimeFlow™ is a robust and sensitive system for RNA flow cytometry, and useful for studying CD163 expression in myeloid cells. CD163 shows distinct patterns of expression in different polarized populations. At single cell resolution, CD163 protein and mRNA levels increased in IL-10 stimulated M2c cells. This flow cytometry panel consisting of CD14, CD16, CD64, CD80, CD163, and CD209 cell surface markers can be used to identify different populations of activated monocytes and macrophages in a broad range of inflammatory disorders.


Disclosure: R. Tan, None; S. Thornton, None; A. Sproles, None; T. Do, None; J. Schick, None; M. DeLay, None; G. Schulert, Novartis Pharmaceutical Corporation, 5.

To cite this abstract in AMA style:

Tan R, Thornton S, Sproles A, Do T, Schick J, DeLay M, Schulert G. Single-Cell Analysis of CD163 mRNA and Protein Expression By Primeflow™ in Polarized Monocyte and Macrophage Populations [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/single-cell-analysis-of-cd163-mrna-and-protein-expression-by-primeflow-in-polarized-monocyte-and-macrophage-populations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-analysis-of-cd163-mrna-and-protein-expression-by-primeflow-in-polarized-monocyte-and-macrophage-populations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology